1887

Journal of General Virology header logo

Volume 96, Issue 8

Development of a Newcastle disease virus vector expressing a foreign gene through an internal ribosomal entry site provides direct proof for a sequential transcription mechanism Free

Abstract

In the present study, we developed a novel approach for foreign gene expression by Newcastle disease virus (NDV) from a second ORF through an internal ribosomal entry site (IRES). Six NDV LaSota strain-based recombinant viruses vectoring the IRES and a red fluorescence protein (RFP) gene behind the nucleocapsid (NP), phosphoprotein (P), matrix (M), fusion (F), haemagglutinin-neuraminidase (HN) or large polymerase (L) gene ORF were generated using reverse genetics technology. The insertion of the second ORF slightly attenuated virus pathogenicity, but did not affect ability of the virus to grow. Quantitative measurements of RFP expression in virus-infected DF-1 cells revealed that the abundance of viral mRNAs and red fluorescence intensity were positively correlated with the gene order of NDV, 3′-NP-P-M-F-HN-L-5′, proving the sequential transcription mechanism for NDV. The results herein suggest that the level of foreign gene expression could be regulated by selecting the second ORF insertion site to maximize the efficacy of vaccine and gene therapy.

  • Received:
  • Accepted:
  • Published Online:
© 2015 The Authors
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.000142
2015-08-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/96/8/2028.html?itemId=/content/journal/jgv/10.1099/vir.0.000142&mimeType=html&fmt=ahah

References

  1. Al-garib S.O., Gielkens A.L., Gruys E., Peeters B.P., Koch G. 2003; Tissue tropism in the chicken embryo of non-virulent and virulent Newcastle diseases strains that express green fluorescence protein. Avian Pathol 32:591–596 [View Article][PubMed]
     [Google Scholar]
  2. Alexander D.J. 1998; Newcastle disease virus and other avian paramyxoviruses. In A Laboratory Manual for the Isolation and Identification of Avian Pathogens, 4th edn. pp. 156–163 Edited by Swayne D., Glisson J. R., Jackwood M. W., Pearson J. E., Reed W. M. Kennett Square, PA: American Association of Avian Pathologists;
     [Google Scholar]
  3. Alexander D.J. 2001; Gordon Memorial Lecture. Newcastle disease. Br Poult Sci 42:5–22 [View Article][PubMed]
     [Google Scholar]
  4. Bai F.L., Yu Y.H., Tian H., Ren G.P., Wang H., Zhou B., Han X.H., Yu Q.Z., Li D.S. 2014; Genetically engineered Newcastle disease virus expressing interleukin-2 and TNF-related apoptosis-inducing ligand for cancer therapy. Cancer Biol Ther 15:1226–1238 [View Article][PubMed]
     [Google Scholar]
  5. Bukreyev A., Huang Z., Yang L., Elankumaran S., St Claire M., Murphy B.R., Samal S.K., Collins P.L. 2005; Recombinant Newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates. J Virol 79:13275–13284 [View Article][PubMed]
     [Google Scholar]
  6. Cardenas-Garcia S., Diel D.G., Susta L., Lucio-Decanini E., Yu Q., Brown C.C., Miller P.J., Afonso C.L. 2015; Development of an improved vaccine evaluation protocol to compare the efficacy of Newcastle disease vaccines. Biologicals 43:136–145 [View Article][PubMed]
     [Google Scholar]
  7. Carnero E., Li W., Borderia A.V., Moltedo B., Moran T., García-Sastre A. 2009; Optimization of human immunodeficiency virus Gag expression by Newcastle disease virus vectors for the induction of potent immune responses. J Virol 83:584–597 [View Article][PubMed]
     [Google Scholar]
  8. de Leeuw O., Peeters B. 1999; Complete nucleotide sequence of Newcastle disease virus: evidence for the existence of a new genus within the subfamily Paramyxovirinae . J Gen Virol 80:131–136[PubMed] [CrossRef]
     [Google Scholar]
  9. DiNapoli J.M., Kotelkin A., Yang L., Elankumaran S., Murphy B.R., Samal S.K., Collins P.L., Bukreyev A. 2007; Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens. Proc Natl Acad Sci U S A 104:9788–9793 [View Article][PubMed]
     [Google Scholar]
  10. DiNapoli J.M., Nayak B., Yang L., Finneyfrock B.W., Cook A., Andersen H., Torres-Velez F., Murphy B.R., Samal S.K. 2010; Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys. J Virol 84:1489–1503 [View Article][PubMed]
     [Google Scholar]
  11. Estevez C., King D., Seal B., Yu Q. 2007; Evaluation of Newcastle disease virus chimeras expressing the hemagglutinin-neuraminidase protein of velogenic strains in the context of a mesogenic recombinant virus backbone. Virus Res 129:182–190 [View Article][PubMed]
     [Google Scholar]
  12. Gaffen S.L., Liu K.D. 2004; Overview of interleukin-2 function, production and clinical applications. Cytokine 28:109–123 [View Article][PubMed]
     [Google Scholar]
  13. Gao Q., Park M.S., Palese P. 2008; Expression of transgenes from Newcastle disease virus with a segmented genome. J Virol 82:2692–2698 [View Article][PubMed]
     [Google Scholar]
  14. Ge J., Deng G., Wen Z., Tian G., Wang Y., Shi J., Wang X., Li Y., Hu S. 2007; Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. J Virol 81:150–158 [View Article][PubMed]
     [Google Scholar]
  15. Ge J., Tian G., Zeng X., Jiang Y., Chen H., Bua Z. 2010; Generation and evaluation of a Newcastle disease virus-based H9 avian influenza live vaccine. Avian Dis 54:(Suppl. 1)294–296 [View Article][PubMed]
     [Google Scholar]
  16. Goff P.H., Gao Q., Palese P. 2012; A majority of infectious Newcastle disease virus particles contain a single genome, while a minority contain multiple genomes. J Virol 86:10852–10856 [View Article][PubMed]
     [Google Scholar]
  17. Hu H., Roth J.P., Estevez C.N., Zsak L., Liu B., Yu Q. 2011; Generation and evaluation of a recombinant Newcastle disease virus expressing the glycoprotein (G) of avian metapneumovirus subgroup C as a bivalent vaccine in turkeys. Vaccine 29:8624–8633 [View Article][PubMed]
     [Google Scholar]
  18. Huang Z., Elankumaran S., Yunus A.S., Samal S.K. 2004; A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV. J Virol 78:10054–10063 [View Article][PubMed]
     [Google Scholar]
  19. Jang S.K., Kräusslich H.G., Nicklin M.J., Duke G.M., Palmenberg A.C., Wimmer E. 1988; A segment of the 5′ nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol 62:2636–2643[PubMed]
     [Google Scholar]
  20. Kolakofsky D., Roux L., Garcin D., Ruigrok R.W. 2005; Paramyxovirus mRNA editing, the ‘rule of six’ and error catastrophe: a hypothesis. J Gen Virol 86:1869–1877 [View Article][PubMed]
     [Google Scholar]
  21. Kong D., Wen Z., Su H., Ge J., Chen W., Wang X., Wu C., Yang C., Chen H., Bu Z. 2012; Newcastle disease virus-vectored Nipah encephalitis vaccines induce B and T cell responses in mice and long-lasting neutralizing antibodies in pigs. Virology 432:327–335 [View Article][PubMed]
     [Google Scholar]
  22. Kortekaas J., de Boer S.M., Kant J., Vloet R.P., Antonis A.F., Moormann R.J. 2010; Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector. Vaccine 28:4394–4401 [View Article][PubMed]
     [Google Scholar]
  23. Krishnamurthy S., Huang Z., Samal S.K. 2000; Recovery of a virulent strain of Newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation. Virology 278:168–182 [View Article][PubMed]
     [Google Scholar]
  24. Lamb R.A., Parks G.D. 2013; Paramyxoviridae. In Fields Virology, 6th edn. pp. 957–995 Edited by Knipe D. M., Howley P. M., Cohen J. I., Griffin D. E., Lamb R. A., Marti M. A. Philadelphia, PA: Lippincott Williams & Wilkins;
     [Google Scholar]
  25. Lamb R.A., Collins P.L., Kolakofsky D., Melero J.A., Nagai Y., Oldstone M.B.A., Pringle C.R., Rima B.K. 2005; Family Paramyxoviridae. In Virus Taxonomy, Eighth Report of the International Committee on Taxonomy of Viruses pp. 655–668 Edited by Fauquet C. M., Mayo M. A., Maniloff J., Desselberger U., Ball L. A. San Diego, CA: Elsevier Academic Press;
     [Google Scholar]
  26. Marcos F., Ferreira L., Cros J., Park M.S., Nakaya T., García-Sastre A., Villar E. 2005; Mapping of the RNA promoter of Newcastle disease virus. Virology 331:396–406 [View Article][PubMed]
     [Google Scholar]
  27. Marschalek A., Finke S., Schwemmle M., Mayer D., Heimrich B., Stitz L., Conzelmann K.K. 2009; Attenuation of rabies virus replication and virulence by picornavirus internal ribosome entry site elements. J Virol 83:1911–1919 [View Article][PubMed]
     [Google Scholar]
  28. Marschalek A., Drechsel L., Conzelmann K.K. 2012; The importance of being short: the role of rabies virus phosphoprotein isoforms assessed by differential IRES translation initiation. Eur J Cell Biol 91:17–23 [View Article][PubMed]
     [Google Scholar]
  29. Miller P.J., Koch G. 2013; Newcastle disease. In Diseases of Poultry, 13th edn. pp. 98–107 Edited by Swayne D. E., Glisson J. R., McDougald L. R., Nolan L. K., Suarez D. L., Nair V. Ames, IA: Wiley-Blackwell Publishing;
     [Google Scholar]
  30. Mountford P.S., Smith A.G. 1995; Internal ribosome entry sites and dicistronic RNAs in mammalian transgenesis. Trends Genet 11:179–184 [View Article][PubMed]
     [Google Scholar]
  31. Niu Z., Bai F., Sun T., Tian H., Yu D., Yin J., Li S., Li T., Cao H. other authors 2014; Recombinant Newcastle disease virus expressing IL15 demonstrates promising antitumor efficiency in melanoma model. Technol Cancer Res Treat (Epub ahead of print)
    [Google Scholar]
  32. Park M.S., Steel J., García-Sastre A., Swayne D., Palese P. 2006; Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc Natl Acad Sci U S A 103:8203–8208 [View Article][PubMed]
     [Google Scholar]
  33. Peeters B.P., de Leeuw O.S., Koch G., Gielkens A.L. 1999; Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. J Virol 73:5001–5009[PubMed]
     [Google Scholar]
  34. Peeters B.P., Gruijthuijsen Y.K., de Leeuw O.S., Gielkens A.L. 2000; Genome replication of Newcastle disease virus: involvement of the rule-of-six. Arch Virol 145:1829–1845 [View Article][PubMed]
     [Google Scholar]
  35. Pelletier J., Sonenberg N. 1988; Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 334:320–325 [View Article][PubMed]
     [Google Scholar]
  36. Römer-Oberdörfer A., Mundt E., Mebatsion T., Buchholz U.J., Mettenleiter T.C. 1999; Generation of recombinant lentogenic Newcastle disease virus from cDNA. J Gen Virol 80:2987–2995[PubMed] [CrossRef]
     [Google Scholar]
  37. Samal S.K. 2011; Newcastle disease and related avian paramyxoviruses. In The Biology of Paramyxoviruses pp. 69–114 Edited by Samal S. K. Wymondham: Caister Academic Press;
     [Google Scholar]
  38. Skiadopoulos M.H., Surman S.R., Durbin A.P., Collins P.L., Murphy B.R. 2000; Long nucleotide insertions between the HN and L protein coding regions of human parainfluenza virus type 3 yield viruses with temperature-sensitive and attenuation phenotypes. Virology 272:225–234 [View Article][PubMed]
     [Google Scholar]
  39. Steward M., Vipond I.B., Millar N.S., Emmerson P.T. 1993; RNA editing in Newcastle disease virus. J Gen Virol 74:2539–2547 [View Article][PubMed]
     [Google Scholar]
  40. Vigil A., Martinez O., Chua M.A., Garcia-Sastre A. 2008; Recombinant Newcastle disease virus as a vaccine vector for cancer therapy. Mol Ther 16:1883–1890 [CrossRef]
     [Google Scholar]
  41. Wen G., Chen C., Guo J., Zhang Z., Shang Y., Shao H., Luo Q., Yang J., Wang H. 2015; Development of a novel thermostable Newcastle disease virus vaccine vector for expression of a heterologous gene. J Gen Virol [Epub ahead of print] [View Article][PubMed]
     [Google Scholar]
  42. Wertz G.W., Moudy R., Ball L.A. 2002; Adding genes to the RNA genome of vesicular stomatitis virus: positional effects on stability of expression. J Virol 76:7642–7650 10.1099/vir.0.000067 [Epub ahead of print]
    [Google Scholar]
  43. Yu Q., Roth J.P., Hu H., Estevez C.N., Zhao W., Zsak L. 2013; Protection by recombinant Newcastle disease viruses (NDV) expressing the glycoprotein (G) of avian metapneumovirus (aMPV) subtype A or B against challenge with virulent NDV and aMPV. World Vaccines 3:130–139 [CrossRef]
     [Google Scholar]
  44. Zhao H., Peeters B.P. 2003; Recombinant Newcastle disease virus as a viral vector: effect of genomic location of foreign gene on gene expression and virus replication. J Gen Virol 84:781–788 [View Article][PubMed]
     [Google Scholar]
  45. Zhao W., Spatz S., Zhang Z., Wen G., Garcia M., Zsak L., Yu Q. 2014; Newcastle disease virus (NDV) recombinants expressing infectious laryngotracheitis virus (ILTV) glycoproteins gB and gD protect chickens against ILTV and NDV challenges. J Virol 88:8397–8406 doi:10.1128/JVI.01321-14 [PubMed] [CrossRef]
     [Google Scholar]
  46. Zhao W., Zhang Z., Zsak L., Yu Q. 2015; P and M gene junction is the optimal insertion site in Newcastle disease virus vaccine vector for foreign gene expression. J Gen Virol 96:40–45 [View Article][PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.000142
Loading
Development of a Newcastle disease virus vector expressing a foreign gene through an internal ribosomal entry site provides direct proof for a sequential transcription mechanism
J. Gen. Virol. 96, 2028 (2015); https://doi.org/10.1099/vir.0.000142
/content/journal/jgv/10.1099/vir.0.000142
/content/journal/jgv/10.1099/vir.0.000142
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error